Skip to main content
. 2022 Sep 22;1(1):e000297. doi: 10.1136/bmjmed-2022-000297

Table 3.

Mean unadjusted within-individual change in cycle length, and adjusted difference in the change from three prevaccination cycle average to first or second vaccination cycle and cycle following the second vaccination cycle, stratified by the number of doses received in a single cycle

Doses per cycle Unvaccinated Vaccinated Adjusted difference in change (days; 99.3% CI)*
No Unadjusted change from prevaccination average
(days; 99.3% CI)
No Unadjusted change from prevaccination average (days; 99.3% CI)
One dose per cycle
 First dose 4686 0.09 (−0.08 to 0.27) 14 193 0.64 (0.53 to 0.76) 0.55 (0.33 to 0.77)
 Second dose 4423 0.21 (0.02 to 0.39) 8857 0.50 (0.36 to 0.64) 0.29 (0.06 to 0.53)
 Cycle after second dose 4134 0.20 (0.01 to 0.39) 8169 0.02 (−0.10 to 0.14) −0.18 (−0.39 to 0.03)
Two doses per cycle
 First and second dose 4686 0.21 (0.02 to 0.39) 743 3.91 (2.53 to 5.28) 3.70 (2.98 to 4.42)
 Cycle after first and second dose 4134 0.20 (0.01 to 0.39) 702 0.85 (0.24 to 1.46) 0.65 (0.13 to 1.18)

Data are mean (99.3% confidence interval), unless otherwise stated. CI=confidence interval.

*Differences between groups come from mixed effects models with random intercepts and slopes at the individual level, an interaction between vaccination status and before and after vaccination timing, and are adjusted for age, body mass index, educational attainment, parity, relationship status, and global region.